Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

  • Single User License $3500

Sulfonamide Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2029

Status : September, 2020 | Chemical & Materials | PPT format

Report Digest

Sulfonamide Market: Introduction

Sulfonamide is a functional group used in various drug formulation which is commonly known as sulpha drugs or sulfa drugs. It is among the first antimicrobial drug used in the treatment of bacterial infections in animals and humans. Sulfonamides act as antimetabolites which block purine and pyrimidine biosynthesis during the synthesis of folic acid, thereby inhibiting bacterial infection. Rising awareness on preventing disease, growing demand for functional food and increasing prevalence of the infectious disease worldwide drive the growth of sulfonamide market. Also, an increase in healthcare expenditure and increasing awareness about health-consciousness results in the growth of the global sulfonamide market and is projected to open new opportunities for the sulfonamide market in the coming future. The global market for sulfonamide is estimated to witness a healthy CAGR during the forecast period of 2020 to 2030.

Sulfonamide Market: Market Dynamics

Increased usage of sulfonamide in treating infectious diseases and the rising popularity of functional food is the key factor augmenting the growth of sulfonamide market globally. Sulfonamide is commonly used in the treatment and prevention of numerous diseases such as bacterial infection, diabetes, HIV AIDS, urinary tract infection, and many more. Thus, an increase in the frequency of chronic disorders worldwide and increasing aging population leads to an increased sulfonamide consumption. Moreover, the ease of availability of various sulfonamide drugs at a reasonable price further contributes to the growth of the global sulfonamides market. Besides, growing R&D activities and government funding in healthcare sector results in the development of innovative and better-quality sulfonamides with enhanced therapeutic activity which further fuels the growth of global sulfonamide market over the forecast period. In addition, rapid development of sulfonamide based dietary supplements is likely to boost the growth of global sulfonamide market. However, side effects associated with sulfonamides such as dizziness, diarrhea, hypersensitivity, kernicterus, and nausea or vomiting and presence of potential substitutes with minor side effects such as macrolides, quinolones are likely to affect the growth of the global sulfonamides market.

Sulfonamide Market: Segmentation

Based on the function, the sulfonamide market is segmented as:

  • Antimicrobial
  • Hypoglycemic
  • Diuretic
  • Anti-epileptic
  • Anti-cancer
  • Anti-protozoal
  • Anti-inflammatory
  • Anti-retroviral

Based on the type, the sulfonamide market is segmented as:

  • Antibiotic
  • Non-antibiotic

Sulfonamide Market: Regional Outlook

Global sulfonamide market is divided into six regions including North America, Latin America, Europe, East Asia, South Asia & Oceania, and Middle East & Africa (MEA). Among the regions mentioned above, sulfonamide is most commonly used in developing countries such as China, India, and ASEAN countries owing to its low prices and ease of availability. China and India with the largest population pool globally have witnessed a high frequency of diseased and infectious people resulting in the growth of sulfonamide consumption. In contrast, the usage of sulfonamide in developed countries has witnessed a downfall due to the seldom appear of sulfonamide in doctor’s prescription and growing awareness about the side effects of sulfonamide. North America is expected to witness steady growth over the forecast period due to growing awareness concerning sulfa drugs, well-developed healthcare infrastructure and presence of harmonized regulatory structure. Europe is likely to witness a similar trend as North America, with moderate growth over the coming years. Latin America is anticipated to grow higher than the global average growth leveraging the low-cost benefits of sulfonamide.

Sulfonamide Market: Market stakeholders

Key market stakeholders in the global sulfonamide market are Boehringer Ingelheim Pharmaceuticals, Abbott Laboratories, GlaxoSmithKline plc, Bayer AG, King Pharmaceuticals, Novartis International AG, Mylan Pharmaceuticals, Teva Pharmaceuticals, Stiefel Laboratories, Roche Holding AG, Sanofi Aventis, Par Pharmaceutical and Pfizer. Bayer AG was the first company to experiment with Prontosil in 1932. The sulfonamide market consists of well-diversified global and regional players with the global vendors ruling the market.

The research report presents a comprehensive assessment of the sulfonamide market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The sulfonamide market report provides analysis and information, according to market segments such as geographies, applications and types.

Sulfonamide Market Report Covers Exhaustive Analysis On:

  • Market Segments
  • Market Dynamics
  • Market Size & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain

The sulfonamide report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The Sulfonamide report provides an in-depth analysis of parent market trends, macroeconomic indicators and governing factors along with market attractiveness as per segments. The sulfonamide report also maps the qualitative impact of various market factors on market segments and geographies.

Sulfonamide Market Report Highlights:

  • A Detailed overview of the parent market
  • Changing market dynamics in the industry
  • In-depth market segmentation
  • Historical, current and projected market size in terms of volume and value
  • Recent industry trends and developments
  • Competitive landscape
  • Strategies of key players and products offered
  • Potential and niche segments, geographical regions exhibiting promising growth
  • A neutral perspective on market performance
  • Must-have information for market players to sustain and enhance their market footprint.

The study presents a granular assessment and quantitative evaluation of:

  • Key growth factors and prominent trends
  • Size and share of key segments in overall market
  • Key challenges and winning imperatives
  • Factors shaping competitive landscape
  • Insights into how contours of market will change in coming years
  • Technological advances
  • New avenues and imminent investment pockets
  • Regulatory landscape shaping current and future strategies of companies

The region-wise assessment includes market dynamics in:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The study is prepared with the help of an extensive primary and secondary research. Primary research includes but not limited to interactions, interviews, surveys, and events. Opinions of policy makers and industry experts are carefully integrated into the insights to complement primary research. Volumes of secondary data gleaned through renowned paid sources, annual statements, reputed journals, and government documents offer insights into current dynamics and key evolution trajectories the market is likely to assume. The research employs various industry-wide analytics methods and well-established methodologies to ascertain the attractiveness of key segments. Further, it evaluates the lucrativeness of key regions and factors underlying their maturity. The insights notably include a detailed analysis of forces behind vendor differentiation and offers insight into investment-decision making by prominent players.

The report strives to enlighten businesses and industry stakeholders on multiple facets of the growth dynamic of the market, the key of which include answers to:

  • Which key factors will shape the competitive landscape?
  • Which trends will stimulate research and development activities in different geographies?
  • Which are the lucrative growth areas and what is the size of potential they are likely contribute to the overall market?
  • Which disruptions in market growth are likely to come with the new business models?
  • Which are some of the recent overhauls in policies that may change the course of the market significantly?
  • Which are the geographies that will form sizable sources of new streams to new and established players alike?
  • How are top players likely to realign their strategy to counter the forces of competition?
  • Which key strategies emerging players are likely to focus on to consolidate their position?
  • Which changes in end-user preferences might affect the status quo held by the leading players?
  • Which are some of the game-changing innovations influencing the projected share and revenue of the market and its segments?

Note: Utmost care has invariably been taken to present data and arrive at statistics at all the TMR Research reports. Meanwhile, some recent developments and new industry trends may take time to be included in the reports.